Immunovant, Inc. (IMVT) - Earnings growth in current year
The annual growth rate of net income per share reflects market expectations, where 11.90 determines the current value of the metric for Immunovant, Inc. (IMVT). Pete Salzman effectively coordinates the development of treatments for autoimmune pathologies, flexibly managing the asset portfolio. A team of top biologists is creating an ambitious antibody pipeline. However, the lack of sales and testing costs are creating a serious liquidity deficit.
Analytical breakdowns and data insights for company Immunovant Inc (IMVT)
- price and consensus price forecast:
- market capitalization indicators:
- book capitalization data:
- debt and liquidity details:
- earnings and market ratios statistics:
IMVT - Company Net Income|Expected Net Profit Immunovant, Inc.|IMVT - Price to Earnings Ratio|Future Price to Earnings Immunovant, Inc.|IMVT - PEG Multiple|EV/EBITDA Multiple Immunovant, Inc.|IMVT - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Immunovant|IMVT - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months immunovant.com|IMVT - Net earnings per share growth this year|Expected earnings per share trend next year Immunovant, Inc.
- sales volume and revenue information:
Basic company analysis:IMVT, Immunovant, Inc.
Assessing the financial stability of Immunovant, Inc. (IMVT) requires an analysis of net income dynamics distributed per share. This annual earnings per share (EPS) growth indicator measures the percentage deviation of the current EPS from the previous year's value, demonstrating the effectiveness of the strategy to capture high-margin niches in autoimmune disease therapy and the maturity of the company's business model amid the development of breakthrough drugs.
Key competitors
Net earnings per share growth this year argenx SE|Net earnings per share growth this year BNTX|Earnings growth in current year Abivax SA|Earnings per share growth in current year ADMA Bio (ADMA)|Protagonist - Earnings per share growth this year|Earnings growth in current year KNSA (kiniksa.com)|Grifols Group (GRFS) - Earnings per share growth rate in current year|Adaptive Biotechnologies Inc. - Earnings growth in current year|Celldex Therapeutics (CLDX) - Net earnings per share growth this year|AUPH (auriniapharma.com) - Net earnings per share growth this year|BCRX - Expected net earnings per share growth this year|Earnings per share growth in current year Vera Pharma|Earnings growth in current year Dianthus Corp|Earnings per share growth in current year Pharvaris N.V. (PHVS)|ABCL - Earnings per share growth rate in current year|Earnings per share growth in current year Tourmaline Bio Inc TRML|Expected net earnings per share growth this year Precigen (PGEN)|Pharming Corp - Earnings growth in current year|Earnings per share increase in current year NKTR (Nektar Therapeutics)|upstreambio.com (UPB) - Earnings per share growth in current year|ZBIO (Zenas Biopharma Inc) - Earnings per share growth in current year|IMNM (Immunome Bio) - Earnings growth in current year|GOSS: Earnings per share increase in current year|Net earnings per share growth this year KALV (KalVista Pharmaceuticals Inc)|SEPN (Septerna Corp) - Earnings per share increase in current year|Earnings growth in current year PVLA (Pieris Corp)|SVRA - Net earnings per share growth this year|RIGL - Earnings per share growth in current year|Earnings per share increase in current year ANAB (AnaptysBio)|ATXS: Earnings growth in current year|ENGN - Expected net earnings per share growth this year|Net earnings per share growth this year RAPT|JBIO: Earnings per share increase in current year|Earnings per share growth in current year Aclaris Therapeutics (ACRS)|KYTX: Earnings per share trend in current year|Earnings growth in current year TLSA (Tiziana Life Sciences, Ltd.)|Expected net earnings per share growth this year Cabaletta Bio Inc (CABA)|ventyxbio.com - Earnings growth in current year|Earnings per share growth rate in current year theratech.com|AVTX: Earnings growth in current year|ELDN: Net earnings per one share growth for the current year|AGEN (Agenus, Inc) - Earnings growth in current year|Climb Bio, Inc. - Earnings per share trend in current year|Earnings per share growth in current year Zura Bio (ZURA)|ATYR - Earnings per share growth rate in current year|Earnings per share growth in current year Adagene ADAG|Earnings per share increase in current year IMA|STTK: Net earnings per share growth this year|Earnings per share increase in current year EQ (equilliumbio.com)|Connect Biopharma Holdings Limited (CNTB) - Earnings per share growth in current year|Immunic, Inc. (IMUX) - Earnings growth in current year|Net earnings per share growth this year ATRA|IFRX: Earnings per share increase in current year|X4 Pharmaceuticals Inc. (XFOR) - Earnings per share increase in current year|Net earnings per share growth this year Adicet ACET|Earnings growth in current year CELU (Celularity Inc)|Earnings growth in current year INmune Bio INMB|Barinthus Biotherapeutics plc - Earnings growth in current year|Kezar Life Sciences, Inc. (KZR) - Net earnings per share growth this year|SAB Biotherapeutics, Inc (SABS) - Earnings per share growth in current year|Net earnings per share growth this year Akari Therapeutics plc|Earnings per share growth in current year enlivex.com|Earnings per share growth rate in current year q32bio.com QTTB|Earnings per share growth in current year GeoVax Labs (GOVX)|EDSA (Edesa Biotech) - Earnings per share increase in current year|Earnings per share growth in current year ibioinc.com IBIO|Earnings growth in current year carismatx.com CARM|XTLB - Earnings per share growth in current year|Earnings per share increase in current year BOLT (boltbio.com)|HCW Biologics Inc (HCWB) - Earnings per share growth in current year|Net earnings per share growth this year Aptevo|Net earnings per share growth this year AIM|Earnings per share growth this year ADTX (aditxt.com)|Earnings per share growth in current year GRI Bio Inc (GRI)|XRTX (XORTX Therapeutics Inc.) - Earnings per share increase in current year|Earnings growth in current year HIND (Vyome Therapeutics)|REVB - Net earnings per share growth this year|INDP: Net earnings per share growth this year|Earnings per share increase in current year SCNI (Scinai)|CALI: Earnings growth in current year|Affimed NV - Earnings per share increase in current year|ALLK (Allakos) - Earnings growth in current year|Earnings per share growth rate in current year hookipapharma.com HOOK|Earnings growth in current year IGMS|ITOS - Earnings per share growth rate in current year|Earnings growth in current year OCEA (oceanbiomedical.com)|Net earnings per one share growth for the current year TCBP (TC Biopharm)|THRD: Net earnings per share growth this year
